All research
2026-06-13 PubMed

IGF-1 Potently Enhances Collagen Deposition and Mechanical Strength in Dermal Tissues, Even from Older Donors

IGF-1 Increases Collagen Deposition by Dermal Fibroblasts: Applications for Tissue Engineering.

Background

Tissue engineering offers a promising avenue for repairing damaged tissues, but age-related declines in extracellular matrix (ECM) deposition by stromal cells often compromise the mechanical integrity of reconstructed tissues. This is particularly critical for conditions like stress urinary incontinence (SUI), which predominantly affects women over 50 years of age. Current treatments often involve synthetic midurethral slings, which have raised concerns regarding safety and long-term tolerance. There's a clear need for strategies to enhance the robustness of biological tissue constructs, and insulin-like growth factor 1 (IGF-1) is a known regulator of cell growth and tissue repair.

Study Design

Researchers investigated biochemical modulation to enhance collagen deposition and mechanical properties in self-assembled dermal tissues. They utilized dermal fibroblasts derived from female donors of different ages, culturing them in the presence of ascorbic acid. The study evaluated the effects of hormonal supplementation (β-estradiol, progesterone), metabolic and hypoxia-related stimuli, and insulin-like growth factor 1 (IGF-1) signaling activation. Primary endpoints included collagen quantification, histological analyses, and mechanical testing to assess tissue robustness.

Results

Fibroblasts from younger donors inherently deposited significantly more collagen than those from older female donors. Among all tested conditions, IGF-1 emerged as a potent enhancer, markedly increasing collagen deposition in a dose-dependent manner. This effect was observed even in fibroblasts from women over 50 years of age. In contrast, β-estradiol and progesterone had no significant effect on collagen content. While β-estradiol did slightly increase tissue thickness, only IGF-1 supplementation led to substantial improvements across multiple mechanical parameters.

IGF-1 supplementation resulted in substantial improvements in perforation strength, stiffness, displacement at break, and toughness of the reconstructed tissues.

Key Findings

  • Younger donor fibroblasts deposited significantly more collagen than older donor fibroblasts.
  • IGF-1 markedly increased collagen deposition in a dose-dependent manner.
  • IGF-1's collagen-boosting effect extended to fibroblasts from women over 50 years of age.
  • β-estradiol and progesterone had no significant effect on collagen content.
  • Only IGF-1 supplementation substantially improved tissue perforation strength, stiffness, displacement at break, and toughness.

Why It Matters

This research highlights IGF-1 as a critical factor for improving the mechanical robustness of bioengineered tissues, particularly those derived from older donors. The finding that IGF-1 can overcome age-related deficits in collagen production suggests a practical strategy for developing more durable and functional biological implants. This could significantly advance the development of biological midurethral slings, potentially reducing reliance on problematic synthetic versions and offering a safer, more biocompatible solution for stress urinary incontinence. The dose-dependent effect also provides a clear pathway for optimizing future tissue engineering protocols.


igf-1 tissue-engineering collagen extracellular-matrix dermal-fibroblasts stress-urinary-incontinence
Source: pubmed:42274614 · Ingested 2026-06-13 · Digest: gemini-2.5-flash